Alnylam Pharmaceuticals, Inc. (LON:0HD2)
London · Delayed Price · Currency is GBP · Price in USD 404.03
+7.24 (1.83%)
At close: Dec 19, 2025
Alnylam Pharmaceuticals Employees
Alnylam Pharmaceuticals had 2,230 employees as of December 31, 2024. The number of employees increased by 130 or 6.19% compared to the previous year.
Employees
2,230
Change (1Y)
130
Growth (1Y)
6.19%
Revenue / Employee
1.07M GBP
Profits / Employee
14.53K GBP
Market Cap
39.54B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2,230 | 130 | 6.19% |
| Dec 31, 2023 | 2,100 | 98 | 4.90% |
| Dec 31, 2022 | 2,002 | 337 | 20.24% |
| Dec 31, 2021 | 1,665 | 212 | 14.59% |
| Dec 31, 2020 | 1,453 | 130 | 9.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| Convatec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Genus | 3,190 |
| HUTCHMED (China) | 1,811 |
Alnylam Pharmaceuticals News
- 3 days ago - Here's How Much $100 Invested In Alnylam Pharmaceuticals 5 Years Ago Would Be Worth Today - Benzinga
- 3 days ago - Alnylam To Expand Massachusetts Manufacturing Facility With $250 Million Investment - Nasdaq
- 3 days ago - Alnylam (ALNY) Advances Norton Facility with $250M Investment - GuruFocus
- 3 days ago - Alnylam to Invest $250 Million to Add Enzymatic Ligation Platform to U.S. Manufacturing Facility to Meet Growing Global Demand for RNAi Therapeutics - Business Wire
- 4 days ago - Is Alnylam Entering A Corrective Phase After A Strong Run? - Benzinga
- 4 days ago - Is Alnylam Entering A Corrective Phase After A Strong Run? - Benzinga
- 5 days ago - Oversold Conditions For Alnylam Pharmaceuticals (ALNY) - Nasdaq
- 5 days ago - Alnylam Pharmaceuticals (ALNY) Rating Maintained, Price Target Lowered by Leerink Partners | ... - GuruFocus